Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria

J Invest Dermatol. 1994 May;102(5):681-5. doi: 10.1111/1523-1747.ep12374134.

Abstract

The molecular defect of uroporphyrinogen decarboxylase (UROD) was examined in a patient with mild hepatoerythropoietic porphyria. To elucidate the UROD defect, we cloned UROD cDNAs from EBV-transformed lymphoblastoid cells of the proband using reverse transcriptase-polymerase chain reaction. Nucleotide sequence analysis of the cloned UROD cDNAs revealed two separate missense mutations, each occurring in a separate allele. One mutation was a Val134-->Gln transition, and was due to three sequential point mutations (T417G418T419-->CCA); the other mutation was a His220-->Pro transition (A677-->C). UROD phenotype studies demonstrated that the TGT-->CCA mutation was inherited from the father, and the A-->C mutation was inherited from the mother. In contrast to the null activity previously described for a mutant UROD from a patient with familial porphyria cutanea tarda, these mutant URODs had subnormal but substantial enzyme activities, when expressed in Chinese hamster ovary cells. This is the first demonstration of a mutation caused by three sequential base substitutions.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Base Sequence
  • Female
  • Gene Deletion
  • Humans
  • Male
  • Molecular Sequence Data
  • Pedigree
  • Point Mutation*
  • Porphyria, Erythropoietic / enzymology*
  • Porphyria, Hepatoerythropoietic / enzymology*
  • Uroporphyrinogen Decarboxylase / genetics*
  • Uroporphyrinogen Decarboxylase / metabolism*

Substances

  • Uroporphyrinogen Decarboxylase